Lanting Capital
VC Fund
Hangzhou, China
Lanting Capital is a venture capital firm that focuses on healthcare industry and especially pharmaceuticals.LTC is founded by pharmaceutical veterans and asset management experts. Lan Ting Capital is a cross-border, pharmaceutical focused strategic consulting and investment firm.LTC leverages their unparalleled industry knowledge and networkplus deep financial market know-how across the US, China and Europe to unlock unique cross-border growth opportunities for our portfolio companies and investors.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Lanting Capital invests in
Stages Lanting Capital invests in
Countries Lanting Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Amy Xu
|
|||
|
Ethan Wu
|
|||
|
Marc Roualet
|
|||
Robert Bloder
|
|||
1 more contact available
Investment Focus
Industry
- Medical 3 (25%)
- Biotechnology 3 (25%)
- Pharmaceutical 3 (25%)
- Robotics 2 (17%)
- Internet of Things 2 (17%)
Stage
- Series A 6 (50%)
- Series B 3 (25%)
- Series C 2 (17%)
- Venture - Series Unknown 1 (8%)
Country
- China 9 (75%)
- United States 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Amy Xu
Investment Director
|
Investment Director | Total investments: 0 | Find email | |
|
Ethan Wu
Chief Executive Officer
|
Chief Executive Officer | Total investments: 0 | Find email | |
|
Marc Roualet
Chief Legal Director
|
Chief Legal Director | Total investments: 0 | Find email | |
|
Robert Bloder
Partner
|
Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Innogen Pharmaceutical
|
Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing, and R&D company. | Venture - Series Unknown / Jul 19, 2022 | |
Rona Therapeutics
|
Rona Therapeutics is a RNA therapeutics platform enabling discovery and development of modular and programmable RNA medicines. | $33M / Series A / Apr 07, 2022 | |
|
Innogen Pharmaceutical
|
Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing, and R&D company. | $120M / Series A / Dec 23, 2021 | |
Yinuo Pharmaceutical
|
Yinuo Pharmaceuticals is a small molecule inhibitor drug developer. | $120M / Series A / Dec 23, 2021 | |
Regor Therapeutics
|
Regor Therapeutics is a clinical-stage company dedicated to the discovery and development of innovative and clinically differentiated medicines by leveraging the proprietary CARD (Computer Accelerated Rational Discovery) Platform, seamlessly integrating structural biology, computational chemistry, therapeutic biology, medicinal chemistry, andclinical development. Regor has assembled a world-class scientific team and demonstrated high efficiency in producing best- and first-in-class molecules. | $90M / Series B / Feb 18, 2021 | |
Yunji Technology
|
Yunji Technology is a Chinese robot company that builds a commercial service robot capable of delivering goods. | $27.8M / Series C / Jan 19, 2021 | |
Immvira
|
Immvira was founded in Shenzhen China in May of 2015 by Prof. Bernard Roizman of University of Chicago and Prof. Grace Zhou formerly a Research Associate Professor at University of Chicago, Prof. Thomas Shenk of Princeton University, Prof. Richard Whitley of University of Alabama, Prof. Ralph Weichselbaum of University of Chicago. | Series C / Dec 31, 2020 | |
|
Green Rice Technology
|
Green Rice Technology is Smart Home Devices Provider Company. | $20M / Series B / Dec 06, 2018 | |
DeepTech
|
DeepTech is a resource empowerment and service organization focusing on emerging technologies. It focuses on the free links of emerging technology elements around the world, serving industries, governments, universities, research institutes, capital, and more. | Series A / Nov 12, 2018 | |
Kuandeng
|
Kuandeng specializes in developing a variety of applications for autonomous driving through the intelligent crowdsourcing of a map. Its core technologies include deep learning, image recognition, 3D vision, robotics, map construction, and big data cloud services based on it. The company has been corporating with a number of car manufacturers withits commitment to productize autonomous driving technology. It has completed several hundred million financings led by IDG Capital. Kuandeng was founded by Liu Jun, former vice president of Baidu and head of the LBS business unit. | $14.2M / Series A / Feb 28, 2018 | |
| See all 12 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Lanting Capital invest in?
Lanting Capital invests primarily in Medical, Biotechnology and Pharmaceutical startups, most often at Series A and Series B stage. Most of the 12 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Lanting Capital?
Public channels for Lanting Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Lanting Capital?
The team at Lanting Capital includes Amy Xu (Investment Director), Ethan Wu (Chief Executive Officer) and Marc Roualet (Chief Legal Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
